When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was ...
Investor's Business Daily on MSN
Gilead leads the battle vs. HIV but rivals are on the move
Gilead stock is closely tied to its HIV treatments. But with Biktarvy's patent expirations looming, can the giant survive?
I have long had a fascination with the grit it takes to be a Manhattan developer. After all, I taught market analysis to a class of approximately 150 graduate students in Columbia’s Master of Science ...
Both Pfizer and Gilead Sciences just flashed the same ominous technical warning while trading below analyst fair value.
Abbott is down nearly 23% this year while Pfizer dangles a 7% yield, and both just beat Q1 estimates. One of these discounts ...
Pfizer is undervalued, trading just over 8x 2026 earnings, with improving dividend yield and core business fundamentals.
Sanofi has sued Pfizer and Moderna , alleging that their COVID-19 vaccines infringe several of the French pharmaceutical ...
With the midterm elections about four months off, Times Opinion asked six polling and politics experts to look into their ...
There's one way to win the AI race, and the big labs are lobbying against it. The answer to Chinese open models is American ...
Argentina are through to the 2026 World Cup Final after overcoming a 1-0 deficit with two late goals to defeat England in regulation. The defending champs will face Spain on Sunday after La Roja ...
LendingTree, Inc. , operator of LendingTree.com, the nation's leading online financial services marketplace, today announced that it will release fiscal second quarter 2026 results after market close ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results